Influence of ph on Adaptive Resistance of Pseudomonas aeruginosa to Aminoglycosides and Their Postantibiotic Effects

Similar documents
Postantibiotic effect of aminoglycosides on Gram-negative bacteria evaluated by a new method

In Vitro Activity of Netilmicin, Gentamicin, and Amikacin

Introduction to Pharmacokinetics and Pharmacodynamics

MICHAEL J. RYBAK,* ELLIE HERSHBERGER, TABITHA MOLDOVAN, AND RICHARD G. GRUCZ

Advance Access published September 16, 2004

Principles of Antimicrobial therapy

Determination of antibiotic sensitivities by the

Antibiotic Resistance in Bacteria

Synergism of penicillin or ampicillin combined with sissomicin or netilmicin against enterococci

Comparative Activity of Netilmicin, Gentamicin, Amikacin, and Tobramycin Against Pseudomonas aeruginosa and Enterobacteriaceae

Selective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016

WHY IS THIS IMPORTANT?

6.0 ANTIBACTERIAL ACTIVITY OF CAROTENOID FROM HALOMONAS SPECIES AGAINST CHOSEN HUMAN BACTERIAL PATHOGENS

Antimicrobials & Resistance

GeNei TM. Antibiotic Sensitivity. Teaching Kit Manual KT Revision No.: Bangalore Genei, 2007 Bangalore Genei, 2007

PDF hosted at the Radboud Repository of the Radboud University Nijmegen

2 0 hr. 2 hr. 4 hr. 8 hr. 10 hr. 12 hr.14 hr. 16 hr. 18 hr. 20 hr. 22 hr. 24 hr. (time)

against Clinical Isolates of Gram-Positive Bacteria

International Journal of Advances in Pharmacy and Biotechnology Vol.3, Issue-2, 2017, 1-7 Research Article Open Access.

Received 17 December 2003; accepted 22 December 2003

مادة االدوية المرحلة الثالثة م. غدير حاتم محمد

Tel: Fax:

ph modulation of aminoglycoside resistance in Staphylococcus epidermidis harbouring 6'-/V-aminoglycoside acetyltransferase

Antibiotic Susceptibility of Pseudomonas aeruginosa

Evaluation of a computerized antimicrobial susceptibility system with bacteria isolated from animals

Received 5 February 2004/Returned for modification 16 March 2004/Accepted 7 April 2004

Protein Synthesis Inhibitors

Antibiotics & Resistance

available. and P. aeruginosa resistant to gentamicin by standardized disk testing (1) in the Microbiology Laboratory

Inhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents

Boosting Bacterial Metabolism to Combat Antibiotic Resistance

Q1. (a) Clostridium difficile is a bacterium that is present in the gut of up to 3% of healthy adults and 66% of healthy infants.

Alasdair P. MacGowan,* Chris A. Rogers, H. Alan Holt, and Karen E. Bowker

SUMMARY OF PRODUCT CHARACTERISTICS. Lincomycin (as Lincomycin hydrochloride) Neomycin (as Neomycin sulphate) Excipients Disodium edetate

ANTIBIOTICS USED FOR RESISTACE BACTERIA. 1. Vancomicin

Journal of Antimicrobial Chemotherapy Advance Access published August 26, 2006

Test Method Modified Association of Analytical Communities Test Method Modified Germicidal Spray Products as Disinfectants

Pharmacological Evaluation of Amikacin in Neonates

TEST REPORT. Client: M/s Ion Silver AB. Loddekopinge. Sverige / SWEDEN. Chandran. min and 30 min. 2. E. coli. 1. S. aureus

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017

European Committee on Antimicrobial Susceptibility Testing

Identification of Factors Affecting In Vivo Aminoglycoside Activity

Mechanism of antibiotic resistance

R-factor mediated trimethoprim resistance: result of two three-month clinical surveys

EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING

Cell Wall Inhibitors. Assistant Professor Naza M. Ali. Lec 3 7 Nov 2017

An evaluation of the susceptibility patterns of Gram-negative organisms isolated in cancer centres with aminoglycoside usage

Introduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018

The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place? Paul M. Tulkens

Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York City

JAC Bactericidal index: a new way to assess quinolone bactericidal activity in vitro

Aminoglycoside-resistant enterococci

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

DOSAGE FORMS AND STRENGTHS Otic Suspension: Each OTIPRIO vial contains 1 ml of 6% (60 mg/ml) ciprofloxacin otic suspension. (3)

Alasdair P. MacGowan*, Mandy Wootton and H. Alan Holt

Antimicrobial agents

Consequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered

MID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

Antimicrobial Resistance

Antimicrobial Resistance Acquisition of Foreign DNA

Lab Exercise: Antibiotics- Evaluation using Kirby Bauer method.

Antimicrobial Pharmacodynamics

VOL. XXIII NO. II THE JOURNAL OF ANTIBIOTICS 559. ANTIBIOTIC 6640.* Ill

Isolation of antibiotic producing Actinomycetes from soil of Kathmandu valley and assessment of their antimicrobial activities

Health Products Regulatory Authority

Studies on Antibiotic Synergism Against Enterococci

Impact of Spores on the Comparative Efficacies of Five Antibiotics. Pharmacodynamic Model

THE STABILITY OF E1VROFLOXA CIN University Undergraduate Research Fellow. A Senior Thesis. Texas ASM University.

Antibacterial susceptibility testing

Title: N-Acetylcysteine (NAC) Mediated Modulation of Bacterial Antibiotic

Y. Q. Xiong*, J. Caillon*, X. Y. Zhou*, G. Potel'*, D. Bugnon', P. Le Conte*, F. Le Gallon*, R. Le Floch', D. Baron* and H.

The Disinfecting Effect of Electrolyzed Water Produced by GEN-X-3. Laboratory of Diagnostic Medicine, College of Medicine, Soonchunhyang University

Other Beta - lactam Antibiotics

Doripenem: A new carbapenem antibiotic a review of comparative antimicrobial and bactericidal activities

Effeet on Bacterial Growth

Antibacterial activity of Stephania suberosa extract against methicillin-resistant Staphylococcus aureus

Antimicrobial agents. are chemicals active against microorganisms

Antibiotics in vitro : Which properties do we need to consider for optimizing our therapeutic choice?

In Vivo Efficacy of the Novel Aminoglycoside ACHN-490 in Murine Infection Models

Some Antibacterial Agents Used with Koi (oz refers to weight unless otherwise specified)

TOLYPOMYCIN, A NEW ANTIBIOTIC. V IN VITRO AND IN VIVO ANTIMICROBIAL ACTIVITY. Masahiro Kondo, Tokiko Oishi and Kanji Tsuchiya

University, New York, New York Received for publication 7 May was measured by the broth dilution method as previously

Evaluation of the AutoMicrobic System for Susceptibility Testing of Aminoglycosides and Gram-Negative Bacilli

Drug resistance in relation to use of silver sulphadiazine cream in a burns unit

Appropriate antimicrobial therapy in HAP: What does this mean?

In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates

Brief reports. Heat stability of the antimicrobial activity of sixty-two antibacterial agents

ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat

Original Article. Ratri Hortiwakul, M.Sc.*, Pantip Chayakul, M.D.*, Natnicha Ingviya, B.Sc.**

Antimicrobial Therapy

ANTIBIOTICS IN PLASMA

Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali. Lec 1

IN VITRO COMBINATION EFFECTS OF NORFLOXACIN, GENTAMICIN, AND Ĉ- LACTAMS ON Ĉ- LACTAM RESISTANT PSEUDOMONAS AERUGINOSA

Prevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre

Ear drops suspension. A smooth, uniform, white to off-white viscous suspension.

ESCMID Online Lecture Library. by author

EDUCATIONAL COMMENTARY - Methicillin-Resistant Staphylococcus aureus: An Update

DETERMINING CORRECT DOSING REGIMENS OF ANTIBIOTICS BASED ON THE THEIR BACTERICIDAL ACTIVITY*

Transcription:

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Jan. 1996, p. 35 39 Vol. 40, No. 1 0066-4804/96/$04.00 0 Copyright 1996, American Society for Microbiology Influence of ph on Adaptive Resistance of Pseudomonas aeruginosa to Aminoglycosides and Their Postantibiotic Effects YAN-QIONG XIONG, JOCELYNE CAILLON, HENRI DRUGEON, GILLES POTEL,* AND DENIS BARON Laboratoire d Antibiologie Clinique et Expérimentale, Faculté demédecine, Centre Hospitalier Universitaire, 44035 Nantes, France Received 12 June 1995/Returned for modification 30 August 1995/Accepted 27 October 1995 Adaptive resistance to aminoglycosides in Pseudomonas aeruginosa and other gram-negative bacilli is usually induced by the initial exposure to the drug. We investigated the influence of ph on the adaptive resistance of a clinical P. aeruginosa strain to aminoglycosides in vitro and on their postantibiotic effects. For adaptive resistance, the first-exposure concentrations of both amikacin and netilmicin were one, two, four, and eight times the MIC of each drug and the second-exposure concentrations were two times the MIC of each drug. Adaptive resistance was greater and more prolonged with higher initial aminoglycoside concentrations, and the bactericidal effects of the aminoglycosides were concentration dependent at ph 7.4. At ph 6.5, the killing rates of amikacin and netilmicin were far lower than those observed at ph 7.4. At ph 5.5, amikacin and netilmicin exerted practically no bactericidal effect on the P. aeruginosa strain used. However, with media at ph 5.5 and 6.5, adaptive resistance of P. aeruginosa preexposed to amikacin and netilmicin was also clearly exhibited, with the degree of adaptive resistance depending on the bactericidal effects of both drugs on nonpreexposed controls. Maximal adaptive resistance occurred between 0 and 4 h after preexposure. The postantibiotic effects of amikacin and netilmicin against the P. aeruginosa strain were shown to be concentration dependent and were reduced at acidic phs. No changes in outer and inner membrane proteins occurred during the adaptiveresistance interval. Adaptive resistance for Pseudomonas aeruginosa and other gram-negative bacilli after exposure to aminoglycosides has been recently described. This reversible form of resistance develops within 2 to 3 h of the initial exposure to an aminoglycoside and then disappears during growth for several hours in a drug-free medium (2, 5, 6). The mechanism of adaptive resistance is not completely understood but is probably related to the reversible downregulation of aminoglycoside uptake during the period of accelerated energy-dependent drug transport (5) and to the decreased proton motive force during the adaptive-resistance interval (reduced killing) (14). Aminoglycosides need to cross the bacterial cytoplasmic membrane before initiating lethal effects. It is well known that increased aminoglycoside uptake is associated with an enhanced bactericidal effect. Previous data have demonstrated that aminoglycoside transport is regulated by, the electrical component of the proton motive force; more specifically, uptake is dependent on (3, 9, 10, 16). Eisenberg et al. indicated that there is generally an increase in the magnitude of at the expense of ph (the transmembrane difference in the H concentration) (9). Moreover, acidic phs seem to have a deleterious effect on aminoglycoside bactericidal activity, although only a few studies have investigated this aspect (12). The purpose of this study was to determine the influence of ph (7.4, 6.5, and 5.5) on the adaptive resistance of P. aeruginosa to amikacin and netilmicin and on the postantibiotic effects (PAEs) of amikacin and netilmicin on P. aeruginosa in vitro as well as to monitor changes in outer and inner membrane proteins during the adaptive-resistance interval. * Corresponding author. Mailing address: Laboratoire d Antibiologie, Faculté de Médecine, 44035 Nantes, France. Phone: (33) 40-08-38-63. Fax: (33) 40-08-46-54. MATERIALS AND METHODS Organism. The P. aeruginosa strain studied was isolated from respiratory secretions and proved susceptible to -lactams, quinolones, and aminoglycosides. Antibiotics. Amikacin and netilmicin, supplied by Bristol Laboratories (Paris, France) and Schering-Plough Laboratories (Levallois-Perret, France), respectively, were dissolved in sterile water. Susceptibility testing. MICs were determined by macrodilution in Mueller- Hinton broth supplemented with Ca 2 and Mg 2 (1), with a final bacterial inoculum of 10 5 to 10 6 CFU/ml. MICs and minimum bactericidal concentrations were defined as the lowest concentrations completely inhibiting growth and killing 99.9% of the inoculum, respectively. PAE. The PAE was assessed by the repeated-washing method, as previously described (4). Cultures were incubated at 37 C in various concentrations of amikacin or netilmicin at different phs (ph 7.4, 6.5, and 5.5) for 1 h prior to removal of the antibiotic by two washes (8,000 g for 10 min) and resuspension of the bacterial pellet in fresh drug-free medium. The PAE was then assessed, and the following equation was formulated for quantitation of the PAE: PAE T C, where T is the time required for the CFU count in the test culture to increase 1 log 10 (10-fold) above that observed immediately after drug removal and C is the time required for the CFU count in an untreated control culture to increase by 1 log 10 above that observed immediately after completion of the same procedure used on the test culture after drug removal. Adaptive resistance in vitro. Adaptive resistance was induced as previously described (5). An overnight culture was diluted 10-fold in Mueller-Hinton broth and incubated with different concentrations of amikacin or netilmicin for 1 h at 37 C. An identical sample of the same culture was simultaneously incubated in drug-free broth and used as a control. After 1 h, bacteria were harvested by centrifugation at 8,000 g for 10 min and washed twice with drug-free medium. The pellet was resuspended and diluted in drug-free broth to yield a suspension of 5 10 4 viable postexposure CFU/ml and was incubated at 37 C. Aliquots of the cultures were removed hourly for 7 h and reexposed to two times the MIC (2MIC) of amikacin or netilmicin. Colony counts were determined before and after exposure, and the difference was expressed as bacterial killing after 90 min. The bacterial killing values for the culture with prior exposure to amikacin or netilmicin were compared with those for the control culture with no prior exposure to antibiotics. Adaptive resistance was observed when the bactericidal effect was less than that noted at the same time point in the control experiment. Outer and inner membrane proteins. Whole-cell preparations and cellular subfractions were isolated as previously described (18). An overnight culture was diluted 10-fold in Mueller-Hinton broth (T 1 ) and incubated with 8MIC of amikacin or netilmicin for 1 h (until T 0 )at37 C. An identical sample of the same culture was simultaneously incubated in drug-free broth and used as a control. After 1 h, bacteria were harvested by centrifugation at 8,000 g for 10 min and 35

36 XIONG ET AL. ANTIMICROB. AGENTS CHEMOTHER. FIG. 1. Antibacterial effects of first and second exposures to amikacin (AMK) against P. aeruginosa in medium at ph 7.4. (A) Bactericidal effect of first amikacin exposure on control culture. (B to E) Bactericidal effects of second amikacin exposure on test cultures. For these panels, the first exposures were MIC, 2MIC, 4MIC, and 8MIC of amikacin, respectively. FIG. 2. Antibacterial effects of first and second exposures to netilmicin (NET) against P. aeruginosa in medium at ph 7.4. (A) Bactericidal effect of first netilmicin exposure on control culture. (B to E) Bactericidal effects of second netilmicin exposures on test cultures. For these pan first exposure is MIC, 2MIC, 4MIC, and 8MIC of netilmicin, respectively.

VOL. 40, 1996 INFLUENCE OF ph ON ADAPTIVE RESISTANCE 37 Downloaded from http://aac.asm.org/ FIG. 3. Antibacterial effects of first and second exposures to amikacin (AMK) against P. aeruginosa in media at different phs. (A to C) Bactericidal effects of first amikacin (2MIC) exposure on control cultures at ph 7.4, 6.5, and 5.5, respectively. (D to F) Bactericidal effects of a second amikacin (2MIC) exposure on test cultures at ph 7.4, 6.5, and 5.5, respectively. The first exposure was to 8MIC of amikacin. washed twice with drug-free medium. The pellet was resuspended and diluted in drug-free broth and incubated at 37 C for7h.att 1,T 0,T 2, and T 7, cells of the control, amikacin, and netilmicin groups were harvested by centrifugation at 8,000 g for 10 min at 4 C (A 600, 0.4 to 0.5). The cells were disrupted by sonication. The differentiation of outer and inner membrane proteins was based on the differential solubilities of these proteins in Sarkosyl. The reaction was stopped with 20% Sarkosyl, and the samples were prepared for sodium dodecyl sulfate-polyacrylamide gel electrophoresis (13). RESULTS PAE. The PAEs of amikacin and netilmicin against P. aeruginosa were shown to be concentration dependent and were reduced at acidic phs (Table 1). At ph 7.4, the PAE of amikacin and netilmicin after exposure to 8MIC of each drug was about 1 h. With lower concentrations, the duration of the PAE was reduced. At ph 6.5, the PAEs of amikacin and netilmicin were shorter than at ph 7.4. At ph 5.5, amikacin exhibited practically no PAE at 4MIC, and netilmicin had only a 0.6-h PAE at 4MIC. Adaptive resistance. The results of adaptive resistance to amikacin and netilmicin (with different concentrations of these compounds after 1 h of preexposure) in the P. aeruginosa strain in ph 7.4 medium are shown in Fig. 1 and 2, respectively. on January 14, 2019 by guest TABLE 1. PAEs for various concentrations of amikacin and netilmicin at different phs a ph MIC/MBC (mg/liter) AMK PAE (h) for drug at concn (mg/liter) NET AMK NET 2 4 8 16 4 8 16 32 7.4 2/4 4/8 0.10 0.35 0.90 1.10 0.13 0.25 0.80 1.00 6.5 2/4 4/8 ND ND 0.70 0.95 ND ND 0.65 0.75 5.5 4/8 8/16 ND ND 0.25 0.10 ND ND 0.00 0.60 a Abbreviations: MBC, minimum bactericidal concentration; AMK, amikacin; NET, netilmicin; ND, not determined.

38 XIONG ET AL. ANTIMICROB. AGENTS CHEMOTHER. Downloaded from http://aac.asm.org/ FIG. 4. Antibacterial effects of first and second exposures to netilmicin (NET) against P. aeruginosa in media at different phs. (A to C) Bactericidal effects of first netilmicin (2MIC) exposure on control cultures at ph 7.4, 6.5, and 5.5, respectively. (D to F) Bactericidal effects of a second netilmicin (2MIC) exposure on test cultures at ph 7.4, 6.5, and 5.5, respectively. The first exposure was to 8MIC of netilmicin. Figure 1 shows that the addition of 2MIC of amikacin (final concentration, 4 mg/liter) in the control culture (without 1-h preexposure) produced bacterial killing of 1.3 to 2.3 log CFU/ ml/90 min at each hourly interval for 7 h (Fig. 1A). The test culture (with 1-h preexposure to 4MIC or 8MIC of amikacin) showed the development and subsequent decline of unstable adaptive resistance when amikacin (4 mg/liter) was added during 7-h growth periods in drug-free medium (Fig. 1D and E). However, with 1-h preexposure to the MIC and 2MIC of amikacin, adaptive resistance was not clearly exhibited (Fig. 1B and C). Figure 2, representing the netilmicin control (Fig. 2A), shows that the addition of 2MIC of netilmicin (final concentration, 8 mg/liter) produced bacterial killing of 1.5 to 2.3 log CFU/ml/90 min at each hourly interval for 7 h. The test culture (Fig. 2B to 2E) clearly showed unstable adaptive resistance to the readdition of netilmicin (8 mg/liter), even with 1-h preexposure to the MIC. The effects of ph (7.4, 6.5, and 5.5) on the adaptive resistance of P. aeruginosa to amikacin and netilmicin are shown in Fig. 3 and 4, respectively. At ph 6.5, the bacterial killing by amikacin (Fig. 3B) was far lower than that at ph 7.4 (Fig. 3A) but was less so for netilmicin (Fig. 4B vs. 4A). At ph 5.5, amikacin and netilmicin had practically no bactericidal effect on the P. aeruginosa strain (Fig. 3C and 4C). For the test group (8MIC of amikacin or netilmicin for 1 h ofpreexposure), the degree and duration of adaptive resistance at ph 6.5 and 5.5 depended on the bactericidal effect of the control, although adaptive resistance was still clearly exhibited. The duration of adaptive resistance was similar with media at different phs (about 3 to 4 h for amikacin and 5 h for netilmicin [Fig. 3D to F and 4D to F]), whereas the intensity was more marked at ph 6.5 than at ph 7.4. After initial drug exposure, the degree of adaptive resistance was very marked at 2 h for amikacin and from 2 to 4 h for netilmicin. Outer and inner membrane proteins. No changes in outer and inner membrane proteins occurred during the adaptiveresistance interval (data not shown). DISCUSSION Few studies have investigated the influence of ph on adaptive resistance of P. aeruginosa to aminoglycosides. As is well known, the bactericidal effect of the aminoglycosides is relative to the ph of the medium (7, 8). In our experiments at ph 5.5, amikacin and netilmicin had practically no bactericidal effect on P. aeruginosa. At ph 6.5, the killing by amikacin and netilmicin was far lower than that at ph 7.4. This resistance phe- on January 14, 2019 by guest

VOL. 40, 1996 INFLUENCE OF ph ON ADAPTIVE RESISTANCE 39 nomenon in media at acidic phs may have been due to a failure of drug uptake. In order to reach their ribosomal intracellular targets, aminoglycosides must traverse the cytoplasmic membranes of bacteria. This process of aminoglycoside uptake contains three energy-dependent phases (EDP). The first phase is binding to the cell surface by ionic interactions. The second phase (EDP-I) requires metabolic energy from the electron transport system that establishes a proton gradient between the inside and outside of the cytoplasmic membrane and is dependent on many factors (e.g., the ph of the medium). The final stage (EDP-II) involves the binding of the drug to ribosomes and necessitates active protein synthesis (8, 17). This final stage could be different from one aminoglycoside to another, possibly explaining some differences in killing rates. Some studies (9, 10, 15) demonstrated that increased aminoglycoside uptake is clearly associated with an enhanced bactericidal effect. Moreover, aminoglycoside uptake is dependent on, the electrical component of the proton motive force. Both aminoglycoside uptake and the subsequent lethal effect are proportional to the magnitude of. However, the magnitude of generally increases as the ph (transmembrane difference in the H concentration) decreases. Over the external ph range from 5.0 to 7.5, both and aminoglycoside uptake increased. Aminoglycoside uptake did not occur at ph 5.0 but was demonstrated at about ph 6.0. Thus, aminoglycoside uptake was clearly dependent on the magnitude of (9, 10, 15). The mechanism of adaptive resistance, although not clearly understood, could be related to reversible aminoglycoside-induced downregulation of drug uptake by bacteria, especially during the period of accelerated energy-dependent drug transport (4), and to a decrease in the magnitude of the electrical potential ( ) during the adaptive-resistance interval (14). We found no changes in outer and inner membrane proteins during the adaptive-resistance interval. The precise mechanisms of the PAE are unknown. Gottfredsson et al. (11) have demonstrated that DNA synthesis, as measured by thymidine uptake, decreases during the PAE and starts to recover about 20 to 40 min prior to growth by viable counts. We have shown that the PAEs of amikacin and netilmicin against the P. aeruginosa strain were reduced at acidic phs. Thus, the mechanism of PAE might be related to ph and. As demonstrated in other studies (2, 5, 6), adaptive resistance is an unstable, reversible form of resistance which develops within 1 to 3 h after initial exposure to an aminoglycoside and disappears several hours after its removal. Our experiments confirm the results of Barclay et al. (2), who used a dynamic model in vitro. They showed that higher initial aminoglycoside concentrations produce greater levels of bactericidal activity and more marked adaptive resistance at ph 7.4. Moreover, we found that adaptive resistance was obtained at lower preexposure concentrations of netilmicin than of amikacin. We evaluated the effects of ph (7.4, 6.5, and 5.5) on the adaptive resistance of P. aeruginosa to aminoglycosides. At ph 6.5 and 5.5, the degree and duration of adaptive resistance depended on the bactericidal effect of the control, although adaptive resistance was still clearly exhibited from 1 to 4 h after the first drug exposure. The durations of adaptive resistance were similar at different phs but seemed related to the antibiotic used (4 h for amikacin, 5 h for netilmicin). The intensity of adaptive resistance was greater at ph 6.5 than 7.4, but it is difficult to relate this result to an increase of the adaptiveresistance phenomenon because at acidic phs the bactericidal activity of the aminoglycosides was decreased. These results suggest that in clinical settings, when the ph of the infectious focus is under 7.4, the in vivo aminoglycoside concentration capable of inducing a bactericidal effect might be far above the MIC. REFERENCES 1. Amsterdam, D. 1991. Susceptibility testing of antimicrobials in liquid media, p. 53 113. In V. Lorian (ed.), Antibiotics in laboratory medicine. The Williams & Wilkins Co., London. 2. Barclay, M. L., E. J. Begg, and S. T. Chambers. 1992. Adaptive resistance following single doses of gentamicin in a dynamic in vitro model. Antimicrob. Agents Chemother. 36:1951 1957. 3. Bryan, L. E., and S. Kwan. 1983. Roles of ribosomal binding, membrane potential, and electron transport in bacterial uptake of streptomycin and gentamicin. Antimicrob. Agents Chemother. 23:835 845. 4. Craig, W. A., and S. Gudmundsson. 1991. Postantibiotic effect, p. 403 431. In V. Lorian (ed.), Antibiotics in laboratory medicine. The Williams & Wilkins Co., London. 5. Daikos, G. L., G. G. Jackson, V. T. Lolans, and D. M. Livermore. 1990. Adaptive resistance to aminoglycoside antibiotics from first-exposure downregulation. J. Infect. Dis. 162:414 420. 6. Daikos, G. L., V. T. Lolans, and G. G. Jackson. 1991. First-exposure adaptive resistance to aminoglycoside antibiotics in vivo with meaning for optimal clinical use. Antimicrob. Agents Chemother. 35:117 123. 7. Damper, P. D., and W. Epstein. 1981. Role of the membrane potential in bacterial resistance to aminoglycoside antibiotics. Antimicrob. Agents Chemother. 20:803 808. 8. Davies, J. E. 1991. Aminoglycoside-aminocyclitol antibiotics and their modifying enzymes, p. 691 713. In V. Lorian (ed.), Antibiotics in laboratory medicine. The Williams & Wilkins Co., London. 9. Eisenberg, E. S., L. J. Mandel, H. R. Kaback, and M. H. Miller. 1984. Quantitative association between electrical potential across the cytoplasmic membrane and early gentamicin uptake and killing in Staphylococcus aureus. J. Bacteriol. 157:863 867. 10. Fraimow, H. S., J. B. Greenman, I. M. Leviton, T. J. Dougherty, and M. H. Miller. 1991. Tobramycin uptake in Escherichia coli is driven by either electrical potential or ATP. J. Bacteriol. 173:2800 2808. 11. Gottfredsson, M., H. Erlendsdottir, A. Gudmundsson, and S. Gudmundsson. 1989. DNA synthesis in S. aureus and E. coli during the postantibiotic effect (PAE) phase, abstr. 935, p. 258. In Program and abstracts of the 29th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C. 12. Gudmundsson, A., H. Erlendsdottir, M. Gottfredsson, and S. Gudmundsson. 1989. The impact of ph and cationic supplementation on the postantibiotic effect (PAE) in vitro, abstr. 936, p. 258. In Program and abstracts of the 29th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C. 13. Hancock, R. E. W., and A. M. Carey. 1979. Outer membrane of Pseudomonas aeruginosa: heat- and 2-mercaptoethanol-modifiable proteins. J. Bacteriol. 140:902 910. 14. Karlowsky, J. A., G. G. Zhanel, R. J. Davidson, and D. J. Hoban. 1994. Aminoglycoside induced adaptive resistance in Pseudomonas aeruginosa correlates with changes in membrane potential and can be eliminated by a H -ATPase inhibitor, abstr. C29, p. 74. In Abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C. 15. Leviton, I. M., H. S. Fraimow, N. Carrasco, T. J. Dougherty, and M. H. Miller. 1995. Tobramycin uptake in Escherichia coli membrane vesicles. Antimicrob. Agents Chemother. 39:467 475. 16. Mates, S. M., E. S. Eisenberg, L. J. Mandel, L. Patel, H. R. Kaback, and M. H. Miller. 1982. Membrane potential and gentamicin uptake in Staphylococcus aureus. Proc. Natl. Acad. Sci. USA 79:6693 6697. 17. Taber, H., W. J. P. Mueller, P. F. Miller, and A. S. Arrow. 1987. Bacterial uptake of aminoglycoside antibiotics. Microbiol. Rev. 51:439 457. 18. Tuomanen, E., and J. Schwartz. 1987. Penicillin-binding protein 7 and its relationship to lysis of nongrowing Escherichia coli. J. Bacteriol. 169:4912 4915.